Spleen tyrosine kinase (Syk) has been shown to play essential roles in inflammatory responses in allergic asthma, and Syk inhibitors have previously evolved as part of a new anti-inflammatory strategy in treating asthma [3, 7, 52]. This evidence concerns the gene SYK and asthma.